Company intelligence / Profile preview

Zhejiang Qianjin Pharmaceutical

Unknown, Zhejiang, Chinaqianjinpharma.com ↗
Ownership
Private
Development stage
Other
01

Overview

Zhejiang Qianjin Pharmaceutical is a private Chinese pharmaceutical company established in 2005 and based in Zhejiang province. The company has focused on developing topical treatments, with its most advanced program being Yuhudie Quban Ointment for melanosis/chloasma. This program reached Phase 3 clinical trials but was discontinued/terminated. There are no other active late-stage programs publicly disclosed as of June 2025.

Therapeutic areas
Dermatology
Modalities
Small moleculeTopical formulation (ointment/cream)
Industry
Biotech
02

Drug pipeline

2 assets

Yuhudie Melasma Ointment

3

1 more asset in the full pipeline.

Beyond the preview

Go deeper on Zhejiang Qianjin Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Qianjin Pharmaceutical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call